Literature DB >> 10681076

Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.

H C Chui1, W Mack, J E Jackson, D Mungas, B R Reed, J Tinklenberg, F L Chang, K Skinner, C Tasaki, W J Jagust.   

Abstract

BACKGROUND: Several clinical criteria have been developed to standardize the diagnosis of vascular dementia (VaD). Significant differences in patient classification have been reported, depending on the criteria used. Few studies have examined interrater reliability.
OBJECTIVE: To assess the concordance in classification and interrater reliability for the following 4 clinical definitions of VaD: the Hachinski Ischemic Score (HIS), the Alzheimer Disease Diagnostic and Treatment Centers (ADDTC), National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN), and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).
METHODS: Structured diagnostic checklists were developed for 4 criteria for VaD, 2 criteria for Alzheimer disease (AD), and 4 criteria for dementia. Twenty-five case vignettes, representing a spectrum of cognitive impairment and subtypes of dementia, were prepared in a standardized clinical format. Concordance in case classification using different criteria and interrater reliability among 7 ADDTCs given a specific set of criteria was assessed using the kappa statistic.
RESULTS: The frequency of a diagnosis of VaD was highest using the modified HIS or DSM-IV criteria, intermediate using the original HIS and ADDTC criteria, and lowest using the NINDS-AIREN criteria. Scores for interrater reliability ranged from kappa = 0.30 (ADDTC) to kappa = 0.61 (original HIS).
CONCLUSIONS: Clinical criteria for VaD are not interchangeable. Depending on the criteria selected, the reported prevalence of VaD will vary significantly. The traditional HIS has higher interrater reliability than the newer criteria for VaD. Prospective longitudinal studies with clinical-pathological correlation are needed to compare validity.

Entities:  

Mesh:

Year:  2000        PMID: 10681076     DOI: 10.1001/archneur.57.2.191

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  47 in total

1.  Diagnosis, risk factors, and treatment of vascular dementia.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

Review 2.  Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Authors:  Marc R Bothe; Ingo Uttner; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2010-01-30       Impact factor: 3.575

3.  Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study.

Authors:  Helen Lavretsky; Ling Zheng; Michael W Weiner; Dan Mungas; Bruce Reed; Joel H Kramer; William Jagust; Helena Chui; Wendy J Mack
Journal:  Am J Psychiatry       Date:  2010-02-16       Impact factor: 18.112

Review 4.  Vascular cognitive impairment.

Authors:  J V Bowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

5.  Personality and risk for Alzheimer's disease in adults 72 years of age and older: a 6-year follow-up.

Authors:  Paul R Duberstein; Benjamin P Chapman; Hilary A Tindle; Kaycee M Sink; Patricia Bamonti; John Robbins; Anthony F Jerant; Peter Franks
Journal:  Psychol Aging       Date:  2011-06

6.  An inverse association of cardiovascular risk and frontal lobe glucose metabolism.

Authors:  B Kuczynski; W Jagust; H C Chui; B Reed
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

Review 7.  Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.

Authors:  Richard Mayeux; Christiane Reitz; Adam M Brickman; Mary N Haan; Jennifer J Manly; M Maria Glymour; Christopher C Weiss; Kristine Yaffe; Laura Middleton; Hugh C Hendrie; Lauren H Warren; Kathleen M Hayden; Kathleen A Welsh-Bohmer; John C S Breitner; John C Morris
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

Review 8.  A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.

Authors:  Jacob S Buckley; Shelley R Salpeter
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

9.  Contribution of vascular pathology to the clinical expression of dementia.

Authors:  Dorothea Strozyk; Dennis W Dickson; Richard B Lipton; Mindy Katz; Carol A Derby; Sunhee Lee; Cuiling Wang; Joe Verghese
Journal:  Neurobiol Aging       Date:  2008-11-08       Impact factor: 4.673

10.  Post-stroke cognitive impairment at 3 months.

Authors:  Uma Sundar; Sikandar Adwani
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.